Incidence of mortality and viral load suppression by clinical characteristics among participants in HIV care facilities in Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Cumulative treatment outcomes prevalence rates for patients in ART treatment from year 2020 to 2022 for study participant in Bauchi State. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis for LTFU according to Viral Load status and BMI status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Annual incidence rate per 100 person-years trend for ART treatment outcomes. by Ekerette Emmanuel Udoh (7326194)

Subjects:

A schematic representation of how BM-MSCs reduce inflammation, oxidative stress, and cell death to alleviate decompression induced acute lung injury. by Chen Lu (135200)

COVID-19 in Lebanon: The daily number of COVID-19 cases throughout the waves of the pandemic in Lebanon and associated SARS-CoV-2 variants between January 2021 and September 2022. by Rima Moghnieh (679199)

Subjects:

Centrifuged FMT products consistently exhibit the lowest median log₁₀ drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the greatest median log₁₀ drop and had a statistically significant loss of bacterial viability across both storage conditions. Products with M:D were the only cryopreserved products to exhibit a significant decrease in surrogate bacterial viability after freezing.... by Nina K. Randolph (21030732)

“…Products with M:D were the only cryopreserved products to exhibit a significant decrease in surrogate bacterial viability after freezing. …”

Three-dimensional visualization of the binary image, illustrating the spatial distribution and morphology of two distinct phases within a cubic volume. The black regions represent... by Mouad Klai (20818364)

Functional and strength parameters. by Susanne S. Rauh (21192252)

“…An overall tendency to an increase in FF and a decrease in functional measures were observed over 2 years. …”

Comparison of study groups based on patients’ variables before and after administration of study drugs. by Nadia Gul (249538)

Subjects:

Flow chart of patient’s recruitment and participation. by Nadia Gul (249538)

Subjects:

Comparative analyses of group 1 vs group 2 based on various patient characteristics. by Nadia Gul (249538)

Subjects:

Frequency of hypoglycemic episodes in group 1 vs group 2. by Nadia Gul (249538)

Subjects:

Demographics and baseline characteristics of patients. by Nadia Gul (249538)

Subjects:

The raw data for Fig 8A. by Hongjoo An (21703199)

“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”

Establishment of a diabetic rat model. by Lan Zeng (638254)

“…Accordingly, we measured VEGF gene expression and found that it was significantly increased in the retinas of diabetic rats (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0312791#pone.0312791.g003" target="_blank">Fig 3A</a>). …”

Table 1_Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.docx by Nourhen Agrebi (14151222)

“…Background<p>Hyper-IgM syndrome (HIGM) is a genetic immunodeficiency characterized by elevated to normal IgM levels and decreased IgG, IgA, and IgE. …”

Fig 4 - by Rima Moghnieh (679199)

Subjects:

Fig 3 - by Rima Moghnieh (679199)

Subjects:

Socio-demographic characteristics of the population. by Sara Saleh (6733619)

Subjects: